55
Views
2
CrossRef citations to date
0
Altmetric
Theme: Heart Failure - Key Paper Evaluation

Wrongfully accused: metformin use in heart failure

&
Pages 147-150 | Published online: 10 Jan 2014

References

  • Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care26(8), 2433–2441 (2003).
  • Held C, Gerstein HC, Yusuf S et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation115(11), 1371–1375 (2007).
  • Dargie HJ, Hildebrandt PR, Riegger GA et al. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in Type 2 diabetic patients with New York Heart Association functional class I or II heart failure. J. Am. Coll. Cardiol.49(16), 1696–1704 (2007).
  • Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ. Heart Fail. DOI: 10.1161/CIRCHEARTFAILURE.110.952556 (2010) (Epub ahead of print).
  • Shah DD, Fonarow GC, Horwich TB. Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. J. Card. Fail.16(3), 200–206 (2010).
  • Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation111(5), 583–590 (2005).
  • Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care22(6), 925–927 (1999).
  • Evans JM, Doney AS, AlZadjali MA et al. Effect of metformin on mortality in patients with heart failure and Type 2 diabetes mellitus. Am. J. Cardiol.106(7), 1006–1010 (2010).
  • UKPDS group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet352(9131), 854–865 (1998).
  • Roussel R, Travert F, Pasquet B et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch. Intern. Med.170(21), 1892–1899 (2010).
  • MacDonald MR, Eurich DT, Majumdar SR et al. Treatment of Type 2 diabetes and outcomes in patients with heart failure: a nested case–control study from the U.K. General Practice Research Database. Diabetes Care33(6), 1213–1218 (2010).
  • Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care28(10), 2345–2351 (2005).
  • Inzucchi SE, Masoudi FA, Wang YF et al. Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction – insights from the National Heart Care Project. Diabetes Care28(7), 1680–1689 (2005).
  • Eurich DT, Tsuyuki RT, Majumdar SR et al. Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials10, 12 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.